Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...

The continent’s leaders are hoping to benefit as the Trump administration cuts support for research and threatens ...

The Trump administration’s unprecedented $500 million grant for a broadly protective flu shot has confounded vaccine and ...

The Herald’s editorial board requested an update to “A scientific dark age threatens to undo decades of progress and ...

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, ...

COVID - 19: The Company reported $84 million in Spikevax® sales in the first quarter of 2025, which includes $29 million of U.S. sales and $55 million of international sales. As previously reported, ...

Hai-Quan Mao and his collaborators at Johns Hopkins conduct materials science research using mRNA and other advances to ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

The research, published April 18 in the journal Science Advances, is proof-of-concept for a technique that could allow neuroscientists to probe previously un-answerable questions about visual ...